» Articles » PMID: 38890721

Advances in Nanomaterial-targeted Treatment of Acute Lung Injury After Burns

Overview
Publisher Biomed Central
Specialty Biotechnology
Date 2024 Jun 18
PMID 38890721
Authors
Affiliations
Soon will be listed here.
Abstract

Acute lung injury (ALI) is a common complication in patients with severe burns and has a complex pathogenesis and high morbidity and mortality rates. A variety of drugs have been identified in the clinic for the treatment of ALI, but they have toxic side effects caused by easy degradation in the body and distribution throughout the body. In recent years, as the understanding of the mechanism underlying ALI has improved, scholars have developed a variety of new nanomaterials that can be safely and effectively targeted for the treatment of ALI. Most of these methods involve nanomaterials such as lipids, organic polymers, peptides, extracellular vesicles or cell membranes, inorganic nanoparticles and other nanomaterials, which are targeted to reach lung tissues to perform their functions through active targeting or passive targeting, a process that involves a variety of cells or organelles. In this review, first, the mechanisms and pathophysiological features of ALI occurrence after burn injury are reviewed, potential therapeutic targets for ALI are summarized, existing nanomaterials for the targeted treatment of ALI are classified, and possible problems and challenges of nanomaterials in the targeted treatment of ALI are discussed to provide a reference for the development of nanomaterials for the targeted treatment of ALI.

References
1.
Long Y, Xiang Y, Liu S, Zhang Y, Wan J, Yang Q . Baicalin Liposome Alleviates Lipopolysaccharide-Induced Acute Lung Injury in Mice via Inhibiting TLR4/JNK/ERK/NF-B Pathway. Mediators Inflamm. 2020; 2020:8414062. PMC: 7673921. DOI: 10.1155/2020/8414062. View

2.
Sun H, Peng M, Lee S, Chen C, Chen W, Yang M . Endotoxin-induced acute lung injury in mice is protected by 5,7-dihydroxy-8-methoxyflavone via inhibition of oxidative stress and HIF-1α. Environ Toxicol. 2015; 31(12):1700-1709. DOI: 10.1002/tox.22172. View

3.
Wang S, Lei P, Feng Y, Jiang M, Liu Z, Shen T . Jinyinqingre Oral Liquid alleviates LPS-induced acute lung injury by inhibiting the NF-κB/NLRP3/GSDMD pathway. Chin J Nat Med. 2023; 21(6):423-435. DOI: 10.1016/S1875-5364(23)60397-8. View

4.
Garcia-Fernandez A, Sancenon F, Martinez-Manez R . Mesoporous silica nanoparticles for pulmonary drug delivery. Adv Drug Deliv Rev. 2021; 177:113953. DOI: 10.1016/j.addr.2021.113953. View

5.
Atmowihardjo L, Heijnen N, Smit M, Hagens L, Filippini D, Zimatore C . Biomarkers of alveolar epithelial injury and endothelial dysfunction are associated with scores of pulmonary edema in invasively ventilated patients. Am J Physiol Lung Cell Mol Physiol. 2022; 324(1):L38-L47. PMC: 9799153. DOI: 10.1152/ajplung.00185.2022. View